The Mark Hughes Foundation funded Brain Cancer Biobank which forms part of the Hunter Cancer Biobank (HCB) and works in collaboration with Brain Cancer Biobanking Australia currently have 4 research projects utilising samples generous provided by patients.
Currently four research projects are working with the samples from the biobank:
- Dr. James Lynam study on predicting clinical toxicity in GBM patients.
- An observational clinical trial. EphA2 as a circulating biomarker for GBM progression.
- A Quality Assurance Project: Glioblastoma circulating tumour cell isolation and detection
- Whole exome sequencing of DNA to reveal the genetics of brain tumour development
